SynthesisTargeted oncology2026

Efficacy and Safety Differences Between Abiraterone and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-analysis of Real-World Studies.

Anikó Katalin Valikovics et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.